“According to a new report published by Introspective Market Research, titled, Targeted Therapy Market by Therapy Type, Indication, and End User, The Global Targeted Therapy Market Size Was Valued at USD 74.9 Billion in 2023 and is Projected to Reach USD 150 Billion by 2032, Growing at a CAGR of 6.83% from 2024–2032.”

Targeted therapy is an advanced form of treatment designed to specifically identify and attack cancer cells or disease-causing molecular pathways while minimizing damage to healthy cells. Unlike conventional therapies such as chemotherapy, targeted therapies act on specific genetic markers, proteins, or cellular mechanisms, leading to improved treatment efficacy and reduced side effects. These therapies are widely used in oncology, immunology, and chronic disease management.

The growing adoption of precision medicine, advancements in biotechnology, and increasing understanding of molecular biology have significantly boosted the demand for targeted therapies. Pharmaceutical and biotechnology companies are investing heavily in research and development to create highly selective drugs tailored to individual patient profiles. As a result, targeted therapy has become a cornerstone in modern cancer treatment protocols.

Major applications of targeted therapy include the treatment of breast cancer, lung cancer, colorectal cancer, leukemia, and autoimmune disorders. Hospitals, specialty clinics, and research institutions are increasingly integrating targeted therapies into standard care practices, driving steady growth of the global targeted therapy market.

Market Segmentation

The Targeted Therapy Market is segmented into Therapy Type, Indication, and End User. By Therapy Type, the market is categorized into Monoclonal Antibodies, Small Molecule Drugs, and Gene Therapy. By Indication, the market is categorized into Breast Cancer, Lung Cancer, Colorectal Cancer, Leukemia, and Others. By End User, the market is categorized into Hospitals, Specialty Clinics, and Research & Academic Institutes.

Growth Driver

The primary growth driver of the targeted therapy market is the rising global prevalence of cancer and chronic diseases. Increasing incidence rates, coupled with growing awareness about early diagnosis and personalized treatment options, are driving demand for targeted therapies. Advances in genomic research and biomarker identification have enabled the development of highly specific drugs, improving patient outcomes. Additionally, favorable regulatory approvals and accelerated drug development pathways are encouraging pharmaceutical companies to expand their targeted therapy portfolios, thereby supporting sustained market growth.

Market Opportunity

A major market opportunity lies in the expansion of targeted therapies in emerging economies. Rapid improvements in healthcare infrastructure, increasing healthcare expenditure, and growing access to advanced diagnostic technologies are creating new growth avenues. Furthermore, ongoing research in combination therapies and next-generation biologics offers significant potential for innovation. Strategic collaborations between biotech firms and research institutions are expected to accelerate product development and commercialization, further expanding the market’s global footprint.

Detailed Segmentation

Targeted Therapy Market, Segmentation

The Targeted Therapy Market is segmented on the basis of Therapy Type, Indication, and End User.

Therapy Type

The Therapy Type segment is further classified into Monoclonal Antibodies, Small Molecule Drugs, and Gene Therapy. Among these, the Monoclonal Antibodies sub-segment accounted for the highest market share in 2023. Monoclonal antibodies are widely used due to their high specificity, strong clinical efficacy, and extensive application across multiple cancer types. Continuous innovation and regulatory approvals have further strengthened their dominance in the targeted therapy landscape.

Indication

The Indication segment is further classified into Breast Cancer, Lung Cancer, Colorectal Cancer, Leukemia, and Others. Among these, the Breast Cancer sub-segment accounted for the highest market share in 2023. The dominance is attributed to high disease prevalence, strong awareness programs, and availability of multiple approved targeted therapies. Ongoing clinical trials and personalized treatment approaches continue to enhance treatment outcomes for breast cancer patients.

Some of The Leading/Active Market Players Are-

• Roche Holding AG (Switzerland)
• Novartis AG (Switzerland)
• Pfizer Inc. (U.S.)
• Johnson & Johnson (U.S.)
• Bristol-Myers Squibb Company (U.S.)
• AstraZeneca plc (UK)
• Merck & Co., Inc. (U.S.)
• Eli Lilly and Company (U.S.)
• Amgen Inc. (U.S.)
• Sanofi S.A. (France)
• Takeda Pharmaceutical Company Limited (Japan)
• Bayer AG (Germany)
• Gilead Sciences, Inc. (U.S.)
• AbbVie Inc. (U.S.)
and other active players.

Key Industry Developments

In March 2024, a leading pharmaceutical company received regulatory approval for a novel targeted therapy for lung cancer.
The therapy demonstrated improved survival rates and reduced adverse effects in clinical trials, strengthening the company’s oncology portfolio and expanding treatment options for patients worldwide.

In October 2023, a major biotech firm announced a strategic collaboration to develop next-generation targeted therapies.
The partnership focuses on precision medicine and biomarker-driven drug development, aiming to accelerate innovation and improve treatment efficacy across multiple cancer indications.

Key Findings of the Study

• Monoclonal antibodies dominate the therapy type segment
• Breast cancer remains the leading indication globally
• North America holds the largest market share
• Rising cancer prevalence is a key growth driver
• Precision medicine is a major market trend

More Info:- https://introspectivemarketresearch.com/reports/targeted-therapy-market/

About Us

At Introspective Market Research Private Limited, we are a forward-thinking research consulting firm committed to driving growth in the Targeted Therapy Market. With deep insights, strategic solutions, and holistic research, we empower businesses to achieve success and dominance in the global Targeted Therapy Market industry.

📞 Contact Us
Introspective Market Research Pvt. Ltd.
Phone: +91-91753-37569
Email: sales@introspectivemarketresearch.com
Web: www.introspectivemarketresearch.com